Michael Timaner

985 total citations
20 papers, 758 citations indexed

About

Michael Timaner is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Michael Timaner has authored 20 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Michael Timaner's work include Cancer Cells and Metastasis (9 papers), Immune cells in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael Timaner is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Immune cells in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael Timaner collaborates with scholars based in Israel, United States and Germany. Michael Timaner's co-authors include Yuval Shaked, Kelvin K. Tsai, Ziv Raviv, Ofrat Beyar‐Katz, Madeleine Benguigui, Dov Hershkovitz, Dror Alishekevitz, Peleg Hasson, Orit Kaidar‐Person and Iris S. Weitz and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Michael Timaner

19 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Timaner Israel 14 359 301 232 170 106 20 758
Gabriel J. Villares United States 18 330 0.9× 666 2.2× 241 1.0× 271 1.6× 56 0.5× 19 1.2k
Lanlan Hui China 8 306 0.9× 411 1.4× 175 0.8× 215 1.3× 35 0.3× 9 848
Shihong Zhao China 15 123 0.3× 447 1.5× 263 1.1× 235 1.4× 135 1.3× 35 897
Clifford J. Whatcott United States 13 773 2.2× 518 1.7× 279 1.2× 237 1.4× 47 0.4× 42 1.3k
Kristina Stumpf United States 4 358 1.0× 286 1.0× 152 0.7× 213 1.3× 31 0.3× 4 693
Dirk Zboralski United States 13 503 1.4× 332 1.1× 218 0.9× 119 0.7× 101 1.0× 22 937
Sharrell B. Lee United States 8 321 0.9× 405 1.3× 176 0.8× 212 1.2× 28 0.3× 9 801
Shelly Maman Israel 9 241 0.7× 263 0.9× 154 0.7× 216 1.3× 25 0.2× 12 649
Marina Kochetkova Australia 19 595 1.7× 534 1.8× 331 1.4× 203 1.2× 44 0.4× 26 1.1k
Stephanie Grebinoski United States 7 353 1.0× 383 1.3× 548 2.4× 327 1.9× 28 0.3× 9 1.0k

Countries citing papers authored by Michael Timaner

Since Specialization
Citations

This map shows the geographic impact of Michael Timaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Timaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Timaner more than expected).

Fields of papers citing papers by Michael Timaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Timaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Timaner. The network helps show where Michael Timaner may publish in the future.

Co-authorship network of co-authors of Michael Timaner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Timaner. A scholar is included among the top collaborators of Michael Timaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Timaner. Michael Timaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Tim J., et al.. (2023). Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene. 42(10). 771–781. 5 indexed citations
2.
Novak, Rostislav, Michael Timaner, Oliver Hartmann, et al.. (2022). RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival. Cell Death and Disease. 13(9). 820–820. 7 indexed citations
3.
Benguigui, Madeleine, et al.. (2022). Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors. Frontiers in Immunology. 13. 903591–903591. 5 indexed citations
4.
Levi-Galibov, Oshrat, Mahesh Devarasetty, Michael Timaner, et al.. (2021). T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy. Cancer Research. 82(2). 278–291. 55 indexed citations
5.
Cooper, Tim J., Ksenya Kveler, Rachelly Normand, et al.. (2021). IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells. Journal for ImmunoTherapy of Cancer. 9(6). e002856–e002856. 23 indexed citations
6.
Timaner, Michael, et al.. (2020). IL-31 induces antitumor immunity in breast carcinoma. Journal for ImmunoTherapy of Cancer. 8(2). e001010–e001010. 14 indexed citations
7.
Beyar‐Katz, Ofrat, Anat Reiner‐Benaim, Irit Avivi, et al.. (2019). Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy. Molecular Cancer Research. 17(11). 2331–2340. 30 indexed citations
8.
Timaner, Michael, Kelvin K. Tsai, & Yuval Shaked. (2019). The multifaceted role of mesenchymal stem cells in cancer. Seminars in Cancer Biology. 60. 225–237. 131 indexed citations
9.
Timaner, Michael, Ziv Raviv, A. Nevelsky, et al.. (2019). Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene. 39(1). 187–203. 42 indexed citations
10.
Benguigui, Madeleine, Iris S. Weitz, Michael Timaner, et al.. (2019). Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells. Scientific Reports. 9(1). 12613–12613. 77 indexed citations
11.
Kveler, Ksenya, Rachelly Normand, Tongwu Zhang, et al.. (2019). A Unique Crosstalk between Tumor Cells and Hematopoietic Stem Cells Reveals a Myeloid Differentiation Pattern Signature Contributing to Metastasis. Blood. 134(Supplement_1). 2465–2465.
12.
Timaner, Michael, Madeleine Benguigui, Ofrat Beyar‐Katz, et al.. (2018). Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells. Cancer Research. 78(5). 1253–1265. 83 indexed citations
13.
Zaffryar‐Eilot, Shelly, Moran Grossman, Dario Ribero, et al.. (2017). Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases. Cell Reports. 19(4). 774–784. 81 indexed citations
14.
Raviv, Ziv, et al.. (2017). The antiangiogenic role of the pro-inflammatory cytokine interleukin-31. Oncotarget. 8(10). 16430–16444. 27 indexed citations
15.
Benguigui, Madeleine, Dror Alishekevitz, Michael Timaner, et al.. (2017). Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach. Oncotarget. 9(2). 2574–2590. 8 indexed citations
16.
Alishekevitz, Dror, Svetlana Gingis‐Velitski, Orit Kaidar‐Person, et al.. (2016). Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3. Cell Reports. 17(5). 1344–1356. 91 indexed citations
17.
Timaner, Michael, Ofrat Beyar‐Katz, & Yuval Shaked. (2016). Analysis of the Stromal Cellular Components of the Solid Tumor Microenvironment Using Flow Cytometry. Current Protocols in Cell Biology. 70(1). 19.18.1–19.18.12. 18 indexed citations
18.
Beyar‐Katz, Ofrat, Dror Alishekevitz, Michael Timaner, et al.. (2016). Bortezomib‐induced pro‐inflammatory macrophages as a potential factor limiting anti‐tumour efficacy. The Journal of Pathology. 239(3). 262–273. 23 indexed citations
19.
Timaner, Michael, Orit Kaidar‐Person, Dror Alishekevitz, et al.. (2015). Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget. 6(29). 27537–27554. 30 indexed citations
20.
Timaner, Michael, Dror Alishekevitz, Tsonwin Hai, et al.. (2015). Host JDP2 expression in the bone marrow contributes to metastatic spread. Oncotarget. 6(35). 37737–37749. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel J. Villares Breakdown of academic impact, for papers by Lanlan Hui Breakdown of academic impact, for papers by Shihong Zhao Breakdown of academic impact, for papers by Clifford J. Whatcott Breakdown of academic impact, for papers by Kristina Stumpf Breakdown of academic impact, for papers by Dirk Zboralski Breakdown of academic impact, for papers by Sharrell B. Lee Breakdown of academic impact, for papers by Shelly Maman Breakdown of academic impact, for papers by Marina Kochetkova Breakdown of academic impact, for papers by Stephanie Grebinoski
Rankless by CCL
2026